pharma · Social Anxiety Disorder · Drug Drug Interaction · VTGN
Vistagen Therapeutics
Vesigen Therapeutics is a pharma organization headquartered in Cambridge, USA. It trades on NYSE under ticker VTGN. Primary therapeutic focus areas include Social Anxiety Disorder, Drug Drug Interaction, Major Depressive
Company details
- Status
- Public
- HQ
- Cambridge, USA
- Employees
- 7
- Programs
- 10
- Drugs
- 3
- Patents
- 6
Quick answer
Vesigen Therapeutics is a pharma organization headquartered in Cambridge, USA. It trades on NYSE under ticker VTGN. Primary therapeutic focus areas include Social Anxiety Disorder, Drug Drug Interaction, Major Depressive Disorder, Parkinson Disease, Social Anxiety Disorder (SAD). NovaPharmaNews links 10 clinical program(s), 0 drug profile(s), and 6 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources. Pipeline phase mix: phase 2 (5), phase 3 (4), phase 1 (1).
Company snapshot
Vesigen is developing groundbreaking therapeutic products directed to intracellular targets using a scalable and extracellular vesicle delivery technology. Our patented technology, called ARMMs (ARRDC1 Mediated Microvesicles), enables us to deliver a wide range of payloads, including RNAs (mRNA, shRNA, ribozymes), proteins (signaling proteins, enzymes, antibody fragments), and editing complexes (C
- 10 active pipeline program(s) linked via ClinicalTrials.gov.
- 6 US patent(s) indexed to this assignee profile.
- 10 trial update(s) in the last 12 months.
Public regulatory, clinical, patent, and corporate records for Vistagen Therapeutics. Not investment advice.
Top assets
Lead pipeline drugs
- Marketed / approved
- Marketed / approved
- Marketed / approved
- Phase 3
Active clinical programs
- Phase 3
- Phase 3
- Phase 3
- Phase 3
Momentum
Proprietary activity score for Vistagen Therapeutics.
1 active signal
Signal breakdown
- Clinical trials
- Nova articles
- Patents filed
- FDA actions
- SEC filings
- Conference presentations
- Pipeline advances
Recent activity
Latest pipeline, patent, and corporate events for Vistagen Therapeutics.
- Clinical update
- Clinical update
- Clinical update
- Clinical update
- Clinical update
Quick answers
Common questions about this sponsor — for analysts and search.
-
What is Vistagen Therapeutics?
-
Is Vistagen Therapeutics publicly traded?
-
What drugs does Vistagen Therapeutics develop or market?
-
What are the latest developments for Vistagen Therapeutics?
-
What therapeutic areas does Vistagen Therapeutics focus on?
Therapeutic focus
Therapeutic area distribution
Pipeline concentration by therapeutic area from linked clinical programs.